Salud financiera de hoja de balance de ImExHS

Salud financiera controles de criterios 5/6

ImExHS tiene un patrimonio de los accionistas total de A$16.0M y una deuda total de A$1.3M, lo que sitúa su ratio deuda-patrimonio en 7.9%. Sus activos y pasivos totales son A$22.7M y A$6.7M respectivamente.

Información clave

7.9%

Ratio deuda-patrimonio

AU$1.27m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	AU$2.36m
Patrimonio	AU$15.98m
Total pasivo	AU$6.67m
Activos totales	AU$22.65m

Actualizaciones recientes sobre salud financiera

Is ImExHS (ASX:IME) Using Too Much Debt?

Mar 09

Recent updates

Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet

Jan 02

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (A$8.9M) de IME superan a sus pasivos a corto plazo (A$6.4M).

Pasivo a largo plazo: Los activos a corto plazo de IME (A$8.9M) superan a sus pasivos a largo plazo (A$297.0K).

Historial y análisis de deuda-patrimonio

Nivel de deuda: IME tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de IME ha crecido de 7.5% a 7.9% en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable IME tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: IME no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 1.9% al año.

Descubre empresas con salud financiera

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Salud financiera de hoja de balance de ImExHS

Salud financiera controles de criterios 5/6

Información clave

Actualizaciones recientes sobre salud financiera

Is ImExHS (ASX:IME) Using Too Much Debt?

Recent updates

ImExHS Limited, Annual General Meeting, Apr 23, 2024

ImExHS Limited has completed a Follow-on Equity Offering in the amount of AUD 1.5 million.

Full year 2023 earnings released: AU$0.10 loss per share (vs AU$0.085 loss in FY 2022)

Price target decreased by 18% to AU$1.50

ImExHS Limited to Report Fiscal Year 2023 Results on Feb 29, 2024

Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet

First half 2023 earnings released: AU$0.055 loss per share (vs AU$0.053 loss in 1H 2022)

ImExHS Limited Provides Revenue Guidance for the Second Half and Full Year of 2023

New minor risk - Financial data availability

New major risk - Revenue and earnings growth

New minor risk - Share price stability

ImExHS Limited (ASX:IME) Screens Well But There Might Be A Catch

Full year 2022 earnings released: AU$0.085 loss per share (vs AU$0.15 loss in FY 2021)

Price target decreased by 10% to AU$1.82

Less than half of directors are independent

Price target decreased to AU$2.03

ImExHS Limited has completed a Follow-on Equity Offering in the amount of AUD 1.975112 million.

First half 2022 earnings released: AU$0.053 loss per share (vs AU$0.092 loss in 1H 2021)

ImExHS Limited to Report First Half, 2022 Results on Aug 30, 2022

ImExHS Limited Revises Earnings Guidance for the Fiscal Year 2022

Consensus forecasts updated

Less than half of directors are independent

Is ImExHS (ASX:IME) Using Too Much Debt?

Full year 2021 earnings: EPS exceeds analyst expectations

ImExHS Limited, Annual General Meeting, May 19, 2022

ImExHS Limited to Report Fiscal Year 2021 Results on Feb 28, 2022

IMEXHS Launches Aquila in the Thai Market

Consensus revenue estimates fall by 11%

ImExHS Limited Provides Consolidated Revenue Guidance for the Fiscal Year 2021

Non-Executive Chairman recently bought AU$64k worth of stock

Independent Non-Executive Director recently bought AU$59k worth of stock

Price target decreased to AU$2.48

Independent Non-Executive Director recently bought AU$99k worth of stock

Full year 2020 earnings released: AU$0.15 loss per share (vs AU$0.31 loss in FY 2019)

Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)

Independent Non-Executive Director recently bought AU$173k worth of stock

Full year 2020 earnings released: AU$0.15 loss per share (vs AU$0.32 loss in FY 2019)

ImExHS Limited to Report Fiscal Year 2020 Results on Feb 26, 2021

Did You Miss ImExHS' (ASX:IME) 60% Share Price Gain?

New 90-day high: AU$2.00

Imexhs Limited Announces Executive Changes

Independent Non-Executive Director recently bought AU$58k worth of stock

First half earnings released

ImExHS Limited announced that it expects to receive AUD 0.5 million in funding from Domatorisaro Pty Ltd

Independent Non-Executive Director recently bought AU$51k worth of stock

ImExHS Limited to Report First Half, 2020 Results on Aug 31, 2020

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera